Mangalam Drugs And Organics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025 along with a copy of minutes.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics held its 52nd Annual General Meeting on Monday, September 29, 2025, through video conferencing, from 3:00 PM to 3:56 PM IST. All 6 directors were present, and 46 members attended the meeting virtually. Five resolutions were tabled for shareholder approval, including adoption of the FY25 standalone audited financial statements, re-appointment of Shri Brijmohan Dhoot (director retiring by rotation), ratification of cost auditor remuneration for FY26, approval of material related party transactions for FY26, and appointment of Ragini Chokshi & Co. as secretarial auditor for a 5-year term. Chairman and Managing Director Govardhan Murlidhar Dhoot addressed shareholders on the company's current and future prospects and corporate governance. The voting results and scrutinizer's report are pending and will be filed with the stock exchanges separately within the prescribed timeline.
This is a routine procedural disclosure with no immediate stock price impact. The listed resolutions — especially the related party transactions and the 5-year secretarial auditor appointment — are standard governance items that typically receive majority approval; investors should watch the upcoming voting results for confirmation.